BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23909500)

  • 1. Liver allocation: urgency of need or prospect of success? Ethical considerations.
    Bobbert M; Ganten TM
    Clin Transplant; 2013; 27 Suppl 25():34-9. PubMed ID: 23909500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
    Schaffer RL; Kulkarni S; Harper A; Millis JM; Cronin DC
    Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MELD and PELD: application of survival models to liver allocation.
    Wiesner RH; McDiarmid SV; Kamath PS; Edwards EB; Malinchoc M; Kremers WK; Krom RA; Kim WR
    Liver Transpl; 2001 Jul; 7(7):567-80. PubMed ID: 11460223
    [No Abstract]   [Full Text] [Related]  

  • 4. MELD-based liver allocation: who is underserved?
    Biggins SW; Bambha K
    Semin Liver Dis; 2006 Aug; 26(3):211-20. PubMed ID: 16850370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Managing a vital resource: liver graft allocation].
    Duvoux C
    Bull Acad Natl Med; 2013 Mar; 197(3):589-98. PubMed ID: 25163342
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of the first year of the new liver allocation plan.
    Freeman RB; Wiesner RH; Edwards E; Harper A; Merion R; Wolfe R;
    Liver Transpl; 2004 Jan; 10(1):7-15. PubMed ID: 14755772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a continuous disease severity score to the OPTN liver waiting list.
    Edwards EB; Harper AM
    Clin Transpl; 2001; ():19-24. PubMed ID: 12211782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
    Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation: evolving patient selection criteria.
    Yu AS; Ahmed A; Keeffe EB
    Can J Gastroenterol; 2001 Nov; 15(11):729-38. PubMed ID: 11727003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time.
    Freeman RB; Rohrer RJ; Katz E; Lewis WD; Jenkins R; Cosimi AB; Delmonico F; Friedman A; Lorber M; O'Connor K; Bradley J
    Liver Transpl; 2001 Mar; 7(3):173-8. PubMed ID: 11244156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era.
    Dutkowski P; Oberkofler CE; Slankamenac K; Puhan MA; Schadde E; Müllhaupt B; Geier A; Clavien PA
    Ann Surg; 2011 Nov; 254(5):745-53; discussion 753. PubMed ID: 22042468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation: an update.
    Said A; Lucey MR
    Curr Opin Gastroenterol; 2006 May; 22(3):272-8. PubMed ID: 16550042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplant considerations for evaluation, CTP, and MELD.
    Mathews SB; Allison W; Lin S
    Crit Care Nurs Clin North Am; 2010 Sep; 22(3):403-11. PubMed ID: 20691390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the MELD/PELD system of liver allocation indications for liver transplantation in the MELD era: evidence-based patient selection.
    Freeman RB
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S2-3. PubMed ID: 15382218
    [No Abstract]   [Full Text] [Related]  

  • 15. The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis.
    Dutkowski P; Oberkofler CE; Béchir M; Müllhaupt B; Geier A; Raptis DA; Clavien PA
    Liver Transpl; 2011 Jun; 17(6):674-84. PubMed ID: 21618688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
    Austin MT; Poulose BK; Ray WA; Arbogast PG; Feurer ID; Pinson CW
    Arch Surg; 2007 Nov; 142(11):1079-85. PubMed ID: 18025337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
    Francoz C; Belghiti J; Castaing D; Chazouillères O; Duclos-Vallée JC; Duvoux C; Lerut J; Le Treut YP; Moreau R; Mandot A; Pageaux G; Samuel D; Thabut D; Valla D; Durand F
    Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplant legislation: ethical and practical issues in liver allocation--The case of Switzerland.
    Kadry Z; Renner EL; Clavien PA
    Liver Transpl; 2001 Jul; 7(7):658-60. PubMed ID: 11460238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status and future of liver transplantation.
    Merion RM
    Semin Liver Dis; 2010 Nov; 30(4):411-21. PubMed ID: 20960380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy.
    Freeman RB; Edwards EB
    Liver Transpl; 2000 Sep; 6(5):543-52. PubMed ID: 10980052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.